Research funder · United States
Alzheimer's Drug Discovery Foundation
Nonprofit organization
- Grants since 2016
- 326
- Awarded, last 5 years (where amounts are published)
- $245.1M
- Funded works, last 5 years
- 1 178
- Funded works, all time
- 2 272
Grants
2016–2017 · research · Drug Discovery
Selective HDAC2 Inhibitors for the Treatment of Cognitive Deficits in Alzheimer's Disease - Year 2, Part 2
Berkley Lynch · Rodin Therapeutics (United States)
2016–2017 · research · Drug Discovery
Novel MR Contrast Agent for Detection of Beta Amyloid
Peter Working · Alzeca Biosciences, Inc.
2016–2017 · research · Clinical
A novel isoform selective kinase inhibitor candidate with in vivo efficacy in two AD models: proposal for GLP tox package for phase 1 IND
Ottavio Arancio · Trustees Of Columbia University In The City Of New York
2016–2020 · research · Clinical
Long-Term Nicotine Treatment of Mild Cognitive Impairment (MCI)
Paul Newhouse · Vanderbilt University
2015–2021 · research · Clinical
Repurposing the PDE5 inhibitor tadalafil for vascular cognitive impairment. A test of concept in older people
Atticus Hainsworth · St George's, University of London
2014–2021 · research · Clinical
Rasagiline Rescue in Alzheimer's Disease Clinical Trial (R2 Trial)
Jeffrey Cummings · Lou Ruvo Brain Institute